About thecannabispages

This author has not yet filled in any details.
So far thecannabispages has created 1490 blog entries.

Claiming Social Care Support for Medical Cannabis Patients in the UK

By |2025-01-19T03:02:04+00:0019 January 2025|

Medical cannabis patients in the UK who receive social care packages from their local authority can apply to have their cannabis-based prescription medicines (CBPM) costs assessed as Disability Related Expenditure (DRE). If accepted, this may reduce the costs of their social care charges but does not cover costs of the cannabis prescription. Understanding Social Care Charges Under Section 14 of the Care Act 2014, local authorities can charge for social care, but they must ensure that such charges are fair and transparent. A financial assessment will determine what an individual can afford, factoring in: The assessment will disregard: Claiming CBPM Costs as DRE Patients can request that their CBPM prescription costs be considered DRE. While many councils have predefined checklists of eligible expenses, additional items may also be considered if supported by evidence. Local authorities must follow the Care Act 2014 principles, which include promoting individual wellbeing, social inclusion, and independence. If prescription costs are not accepted as DRE, it could be considered a breach of the Act, especially if this impacts a patient’s wellbeing or independence. Supporting Your Claim To claim CBPM costs as DRE, patients must provide evidence demonstrating: Unfortunately, many councils may not accept evidence from medical cannabis prescribers and instead require support from a GP and/or healthcare consultant. Patients are encouraged to request a supporting letter from their GP or healthcare consultant, detailing the necessity of CBPM and its role in reducing other treatments, such as opioids. If Your Claim Is Denied If a local authority rejects your request to classify CBPM costs as DRE, you can: The Ombudsman can recommend remedies for councils to implement. While their recommendations are not legally binding, councils rarely refuse to comply. Ensure that all medical evidence is shared with the Council and the Ombudsman. Example Case In a recent case (LGSCO reference: 24 001 331), Brighton & Hove City Council was found at fault for mishandling a social care assessment. Patients can use such precedents to support their claims. In the recent review by the Local Government and Social Care Ombudsman (LGSCO), significant concerns were raised regarding how a council handled a patient’s request to include medical cannabis costs as Disability Related Expenditure (DRE): Implications This case highlights the importance of councils adhering to their legal duty to consider all relevant evidence and provide transparent justifications for their decisions. Patients who encounter similar challenges are encouraged to challenge such decisions through formal complaints and escalate them to the Ombudsman if necessary. Key Takeaways For further guidance: Local Government and Social Care Ombudsman: https://www.lgo.org.uk/ Care Act Statutory Guidance: https://www.gov.uk/government/publications/care-act-statutory-guidance/care-and-support-statutory-guidance Medical Cannabis as Disability Related Expenditure Social Care Case Playlist by Cannabis is Medicine UK: https://www.youtube.com/playlist?list=PLmL0L5mPiFAUwDl6bG51wPOu-53MGGQMo By understanding the process and advocating for your rights, you can ensure fair consideration of your medical cannabis prescription costs within your social care assessment.

The post Claiming Social Care Support for Medical Cannabis Patients in the UK first appeared on PatientsCann UK.

 A Dive into Medical Cannabis for Adult ADHD – A Sociological Case Report

By |2025-01-16T03:16:02+00:0016 January 2025|

Meet our main character: a 33-year-old guy who got slapped with an unexpected ADHD diagnosis later in life. His first treatment? Good old Ritalin. Things started off fine – until they didn’t. After some nasty side effects and a merry-go-round of alternative meds, our patient stumbled upon something a bit more… natural. Enter prescription cannabis. […]

The post  A Dive into Medical Cannabis for Adult ADHD – A Sociological Case Report appeared first on I Am Billy.

Prescription Cannabis V Opioids in Chronic Pain – Who’s Got the Holistic Edge?

By |2025-01-16T03:15:58+00:0016 January 2025|

Chronic pain – that nagging discomfort that sticks around for at least three months like an unwelcome houseguest.   40 prescription cannabis users  V     161 opioid users Both opioids and prescription cannabis are the go-to contenders for pain relief. Opioids are like the heavyweight champs – quick and effective at knocking out pain, whether it’s […]

The post Prescription Cannabis V Opioids in Chronic Pain – Who’s Got the Holistic Edge? appeared first on I Am Billy.

Network Rail’s Medical Cannabis Policy: A Cause for Concern

By |2025-01-13T20:45:55+00:0013 January 2025|

At PatientsCann UK, we are deeply concerned by Network Rail’s recently issued safety advice (NRA24-13), which imposes a blanket ban

The post Network Rail’s Medical Cannabis Policy: A Cause for Concern first appeared on PatientsCann UK.

Can Prescription Cannabis Help Tame Fibro Pain?

By |2025-01-13T03:11:58+00:0013 January 2025|

A trial went down at the San Carlo Hospital’s pain therapy unit in Potenza, Italy, using prescription cannabis in patients with fibromyalgia.  The Scoop;  Patients with fibromyalgia saw their pain intensity (on the trusty NRS scale) nosedive from an eye-watering 8 to a manageable 4 over just 6 months.   Things didn’t just stop at pain […]

The post Can Prescription Cannabis Help Tame Fibro Pain? appeared first on I Am Billy.

UK IBD Patients Report Improvements With Medical Cannabis

By |2025-01-10T03:06:39+00:0010 January 2025|

Inflammatory bowel disease (IBD) patients in the UK have reported improvements in their condition following treatment with medical cannabis.  According to observational data published in the journal Expert Review of Gastroenterology & Hepatology, medical cannabis treatment was associated with sustained improvements in health-related quality of life [...]

What’s in Store for the European Cannabis Industry in 2025? (Part 2)

By |2024-12-22T03:04:02+00:0022 December 2024|

Written by Ben Stevens and Sarah Sinclair.  You can read Part 1 here.  Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly following the regulatory changes in Germany. Ukraine’s Health Minister, Viktor Liashko, visited Germany this year as [...]

Comments Off on What’s in Store for the European Cannabis Industry in 2025? (Part 2)

What’s in Store for the European Cannabis Industry in 2025? (Part 1)

By |2024-12-22T03:03:50+00:0022 December 2024|

Written by Ben Stevens and Sarah Sinclair.    2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes and policy.  It was a year dominated by elections, with around half of the world’s population [...]

Comments Off on What’s in Store for the European Cannabis Industry in 2025? (Part 1)

CBD Linked To ‘Lower Overall Anxiety’ In Breast Cancer Patients

By |2024-12-22T03:03:41+00:0022 December 2024|

In a new study researchers explored whether CBD can reduce scan-related anxiety in patients with advanced breast cancer. The findings showed that while CBD did not significantly change scan-related anxiety when compared to a placebo, it was safe and resulted in significantly lower overall anxiety levels [...]

Comments Off on CBD Linked To ‘Lower Overall Anxiety’ In Breast Cancer Patients

French Medical Cannabis Patients Warned Treatment Will be ‘No Longer Accessible From January’

By |2024-12-20T03:00:38+00:0020 December 2024|

Via Business of Cannabis French patient associations have warned that medical cannabis patients could soon face a disruption in treatment as its long-running experiment comes to an end with no next steps in place. The French Society for the Study and Treatment of Pain (SFETD) issued [...]

Comments Off on French Medical Cannabis Patients Warned Treatment Will be ‘No Longer Accessible From January’

Next Phase of Dutch Cannabis Experiment To Launch April 2025

By |2024-12-18T03:03:19+00:0018 December 2024|

From April 2025, Dutch coffee shops will only be permitted to sell regulated cannabis products, as the next phase of the country’s adult-use pilot gets underway. One year on from the launch of the Netherlands’ Closed Coffee Shop Chain Experiment, regulators have set a fixed date [...]

Comments Off on Next Phase of Dutch Cannabis Experiment To Launch April 2025

New Data Supports Use Of Epidiolex In Tuberous Sclerosis Complex

By |2024-12-12T03:01:04+00:0012 December 2024|

Jazz Pharmaceuticals has shared new data to support the efficacy of Epidiolex in patients with tuberous sclerosis complex (TSC).  Research shared at the American Epilepsy Society (AES) 2024 Annual Meeting held from 6-10 December in Los Angeles, California supports the use of Epidiolex in the treatment [...]

Comments Off on New Data Supports Use Of Epidiolex In Tuberous Sclerosis Complex

FDA Approves Clinical Trial On Cannabis In Veterans With PTSD

By |2024-12-11T03:04:42+00:0011 December 2024|

MAPS (Multidisciplinary Association for Psychedelic Studies) has secured FDA clearance to conduct a clinical trial examining the use of smoked cannabis for the treatment of PTSD symptoms among veterans. After three years of negotiation, the FDA has given MAPS the green light to carry out a [...]

Comments Off on FDA Approves Clinical Trial On Cannabis In Veterans With PTSD

UK’s First Authorised CBD Products Expected by Spring 2025

By |2024-12-11T03:04:27+00:0011 December 2024|

Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval by Spring next year. While this announcement comes nearly seven years after the novel [...]

Comments Off on UK’s First Authorised CBD Products Expected by Spring 2025

GPs in Czech Republic Permitted To Prescribe Medical Cannabis From 2025

By |2024-12-06T03:10:37+00:006 December 2024|

Thousands more doctors in the Czech Republic will soon be permitted to prescribe medical cannabis under a new decree published by the Ministry of Health. From April 2025, the country’s 5,000 general practitioners will be permitted to prescribe medical cannabis to patients with chronic pain, following [...]

Comments Off on GPs in Czech Republic Permitted To Prescribe Medical Cannabis From 2025

Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials

By |2024-12-04T03:00:23+00:004 December 2024|

Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major trials using its proprietary compounds. Last month, Business of Cannabis reported that two long-awaited NHS clinical trials to [...]

Comments Off on Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials

CBD Shows Promise in Treatment of Endometriosis, Say Leading Women’s Health Researchers

By |2024-11-30T03:09:07+00:0030 November 2024|

Researchers from the Centre for Reproductive Health at the University of Edinburgh have co-authored a new review paper highlighting the potential of CBD in the treatment of endometriosis. The new paper, published in the top-ranking journal Trends in Pharmacological Science (TIPS), finds that CBD is a [...]

Comments Off on CBD Shows Promise in Treatment of Endometriosis, Say Leading Women’s Health Researchers

French Health Officials Recommended Medical Cannabis Framework in 2023, Report Reveals

By |2024-11-29T03:05:09+00:0029 November 2024|

A newly-obtained report by France’s Directorate General of Health (DGS) evaluating the impact of the medical cannabis pilot, recommended the roll out of a temporary  regulatory framework last year. The Union of Industrialists for the Valorization of Hemp Extracts (UIVEC) in France says the report, dated [...]

Comments Off on French Health Officials Recommended Medical Cannabis Framework in 2023, Report Reveals

Germany Hosts EU Leaders to Exchange Insights on Cannabis Regulation 

By |2024-11-28T03:04:50+00:0028 November 2024|

Representatives from five European countries, as well as the European Union Drug Agency (EUDA), met in Germany last week to discuss the regulation of cannabis for non-medical purposes.  European leaders from Luxembourg, Malta, the Netherlands and Czech Republic attended an international ministerial exchange in Germany to [...]

Comments Off on Germany Hosts EU Leaders to Exchange Insights on Cannabis Regulation 

New Era for Medical Cannabis in Denmark as Government Announces Plans for Permanent Legal Framework

By |2024-11-27T03:03:45+00:0027 November 2024|

Via Business of Cannabis Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week. The Danish pilot scheme has been running since 2018, and has continued to expand in both scope and [...]

Comments Off on New Era for Medical Cannabis in Denmark as Government Announces Plans for Permanent Legal Framework

Luxembourg to Restrict Access to Medical Cannabis Flower on Prescription

By |2024-11-21T03:14:18+00:0021 November 2024|

Luxembourg is set to restrict access to high-THC cannabis flower on prescription from next year, as part of longer term plans to phase out flower-based products altogether. As of January 2025, patients in Luxembourg will no longer be able to access cannabis flower containing high levels [...]

Comments Off on Luxembourg to Restrict Access to Medical Cannabis Flower on Prescription

Long-term cannabis use not linked to cognitive decline — study

By |2024-11-20T03:12:41+00:0020 November 2024|

New research has found no association between long-term cannabis use and cognitive decline in later life.  Longitudinal data published in the journal Brain and Behavior, found no significant harmful effects of cannabis use on age-related cognitive decline.  Researchers in Denmark examined the relationship between lifetime cannabis [...]

Comments Off on Long-term cannabis use not linked to cognitive decline — study

What Does the Collapse of Germany’s Government Mean for Cannabis?

By |2024-11-15T03:01:36+00:0015 November 2024|

Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic light coalition all but collapsed, throwing the future of Europe’s largest and most promising cannabis market into uncertain territory. On [...]

Comments Off on What Does the Collapse of Germany’s Government Mean for Cannabis?

Brain changes linked to cannabis use may not be causal, finds study

By |2024-11-14T03:09:32+00:0014 November 2024|

Lifetime cannabis use is associated with several changes in brain structure and function in later life, suggests an observational study, but these associations may not be causal. This is according to researchers who conducted a genetic analysis of data from over 15,000 cannabis consumers in the [...]

Comments Off on Brain changes linked to cannabis use may not be causal, finds study

First study finds CBN improves sleep without intoxicating effects

By |2024-11-13T03:18:54+00:0013 November 2024|

A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep without any intoxicating effects.  Research by scientists at the University of Sydney is the first to use objective measures to show the component, known as cannabinol (CBN), increases sleep in [...]

Comments Off on First study finds CBN improves sleep without intoxicating effects

NHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access

By |2024-11-07T03:04:10+00:007 November 2024|

Six years on from the legalisation of medical cannabis in the UK, families have made a fresh call for NHS access, as new figures reveal lack of prescribing. Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, [...]

Comments Off on NHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access

Oireachtas Committee Pushes Decriminalisation of Cannabis in Ireland

By |2024-11-06T03:21:46+00:006 November 2024|

The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of Ireland’s landmark Citizens’ Assembly on Drugs Use, coming out strongly in favour of decriminalisation. Established earlier this year to further scrutinise the recommendations of the Citizens Assembly, the specialist committee was given until [...]

Comments Off on Oireachtas Committee Pushes Decriminalisation of Cannabis in Ireland

UK Medical Cannabis: Marking Six Years of Access & Looking Ahead

By |2024-11-02T03:12:14+00:002 November 2024|

Six years ago today, the UK took a step forward, allowing eligible patients to access medical cannabis for chronic physical and mental health conditions. This November, we celebrate the anniversary of this landmark decision and reflect on the journey so far. Tens of thousands of patients [...]

Comments Off on UK Medical Cannabis: Marking Six Years of Access & Looking Ahead

Dramatic drop in cannabis use among US teens, finds study

By |2024-11-01T03:00:21+00:001 November 2024|

New findings have identified a significant decline in the percentage of US adolescents reporting current cannabis use over the last decade.  The study, published in the journal Pediatric Reports, reveals that in 2011, 23.1% of adolescents indicated they were current users, but by 2021, this figure [...]

Comments Off on Dramatic drop in cannabis use among US teens, finds study

Nationwide awareness drive to mark six years of medical cannabis in the UK

By |2024-10-31T03:03:52+00:0031 October 2024|

Events will take place at several major cities around the UK to raise awareness and bring medical cannabis education directly to the public.  Patient advocates will visit Belfast, Birmingham, Glasgow, Cardiff and London throughout Medical Cannabis Awareness Week (1-7 November), to share their personal experiences and [...]

Comments Off on Nationwide awareness drive to mark six years of medical cannabis in the UK

The Hidden Dangers of Illicit Cannabis

By |2024-10-25T03:05:52+01:0025 October 2024|

A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re committed to providing the highest standard of medical cannabis care, guided by science. As such, we are concerned about the growing number of people buying cannabis from illegal sources, including online [...]

Comments Off on The Hidden Dangers of Illicit Cannabis

118% Surge in UK Cannabis Prescriptions Highlights Awareness Challenges

By |2024-10-25T03:05:37+01:0025 October 2024|

Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind. After almost six years of medical cannabis being available on prescription in the UK, the numbers [...]

Comments Off on 118% Surge in UK Cannabis Prescriptions Highlights Awareness Challenges

Economic analysis finds medical cannabis could save NHS £4 billion each year

By |2024-10-24T03:10:05+01:0024 October 2024|

Prescribing medical cannabis for chronic pain could save the NHS almost £4 billion annually, according to new research. The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain, undertaken by York Health-Economics Consortium at the University of York.  Researchers [...]

Comments Off on Economic analysis finds medical cannabis could save NHS £4 billion each year

Germany Green-Lights Changes to Medical Cannabis Prescription Process

By |2024-10-23T03:07:12+01:0023 October 2024|

The majority of doctors in Germany can now prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies. It comes amid reports suggesting the German pharmacies are now key beneficiaries of the medical cannabis market, bringing in tens of thousands of euros [...]

Comments Off on Germany Green-Lights Changes to Medical Cannabis Prescription Process

New publication evidences role of medical cannabis in epilepsy

By |2024-10-18T03:11:09+01:0018 October 2024|

UK medical cannabis experts have published a comprehensive review of evidence for the prescription of cannabis-based medicines in epilepsy. With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy, published by Maple Tree Consultants, provides the first review of nearly 100 clinical trials, real-world studies, and [...]

Comments Off on New publication evidences role of medical cannabis in epilepsy

Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024

By |2024-10-18T03:11:00+01:0018 October 2024|

Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. [...]

Comments Off on Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024

UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For

By |2024-10-18T03:10:46+01:0018 October 2024|

By Sarah Sinclair with additional reporting from Ben Stevens (Business of Cannabis) Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy. The first significant update on the trials—first promised in [...]

Comments Off on UCL Launches 2 Medical Cannabis Trials Into Childhood Epilepsy, but Experts Warn It Is Not the Solution Many Have Been Waiting For

UK Private Medical Cannabis Market Sees Exponential Growth, Doubling Yearly Since 2021

By |2024-10-18T03:10:30+01:0018 October 2024|

The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion. According to the latest figures from the NHS Business Services Authority (NHSBSA), published in response to an FOI request, the number of [...]

Comments Off on UK Private Medical Cannabis Market Sees Exponential Growth, Doubling Yearly Since 2021

Ukraine excludes PTSD from list of approved conditions for medical cannabis

By |2024-10-10T03:01:52+01:0010 October 2024|

Ukraine’s Ministry of Health has approved the draft list of conditions for which medical cannabis can now be prescribed, excluding PTSD and other mental health disorders until more research is available. The impact of trauma and PTSD following Russia’s invasion of Ukraine played a key role [...]

Comments Off on Ukraine excludes PTSD from list of approved conditions for medical cannabis

Clinical trial shows dronabinol reduces agitation in Alzheimer’s disease

By |2024-10-09T03:16:33+01:009 October 2024|

The THC-based drug dronabinol has been shown to reduce agitation in Alzheimer’s patients without adverse effects. Researchers have shown that a pill form of the drug dronabinol, an FDA-approved synthetic version of THC, reduces agitation in patients with Alzheimer’s by an average of 30%. The researchers [...]

Comments Off on Clinical trial shows dronabinol reduces agitation in Alzheimer’s disease

Spain’s proposed medical cannabis framework too ‘restrictive’, say patients

By |2024-10-03T03:08:22+01:003 October 2024|

Spanish regulators have taken another step towards introducing the country’s long-delayed medical cannabis framework, but patients say the legislation does not go far enough. On Monday 30 September, the Ministry of Health published a draft royal decree for public hearing, setting out the proposed regulations for [...]

Comments Off on Spain’s proposed medical cannabis framework too ‘restrictive’, say patients

National education programs needed to tackle ‘stigma’ and ‘inequality’ facing medical cannabis patients

By |2024-10-02T03:11:59+01:002 October 2024|

Drug policy experts are calling for national education programs to tackle the lack of awareness and ‘stigmatising attitudes’ towards medical cannabis patients. In a new paper, researchers from Liverpool John Moores University, have highlighted how current policies, and a lack of training for professionals, are contributing [...]

Comments Off on National education programs needed to tackle ‘stigma’ and ‘inequality’ facing medical cannabis patients

New poll sheds light on patterns of cannabis use among over 50s

By |2024-09-27T03:10:37+01:0027 September 2024|

A large percentage of people in their 50s and older have consumed at least one form of cannabis in the past year, a new US poll shows. According to new findings from the University of Michigan National Poll on Healthy Aging, 21% of people aged 50 [...]

Comments Off on New poll sheds light on patterns of cannabis use among over 50s